Upregulation of the antithrombotic protein C pathway at birth

Pediatric Hematology and Oncology

Volumn 15, Issue 6, 1998, Pages 489-499

  Petäjä, Jari ^a,b   Fernández, José A ^a   Fellman, Vineta ^b   Griffin, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Factor V; Infant; Neonate; Protein C; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; PROTEIN C; PROTEIN INHIBITOR;

ANTICOAGULATION; ARTICLE; BIRTH; CONTROLLED STUDY; FEMALE; HALF LIFE TIME; HUMAN; MALE; NEWBORN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; THROMBOSIS; UMBILICAL CORD BLOOD;

EID: 0031752790     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019809018310     Document Type: Article

References (49)

1. Manco-Johnson M, Abshire TC, Jacobson LJ, Marlar RA. Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr. 1991;119:793-798.
2. Petäjä J, Lundström U, Sairanen H, Marttinen E, Griffin JH. Central venous thrombosis after cardiac surgery in children. J Thorac Cardiovasc Surg. 1996;112:883-889.
3. Berman W, Fripp RR, Yabek SM, Wernly J, Corlew S. Great vein and right atrial thrombosis in critically ill infants and children with central venous lines. Chest. 1991;99:963-967.
4. Nowak-Gȯttl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Hematol 1996;92:992-998.
5. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood. 1994;83:1251-1257.
6. Hirsh J, Prins MH, Samama M. Approach to the thrombophilic patient. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott; 1994:1543-1561.
7. Mahasandana, C, Suvatte V, Chuansumrit A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr. 1990;117:750-753.
8. Marlar R, Montgomery R, Broekmans A. Diagnosis and treatment of homozygous protein C deficiency. J Pediatr. 1995;114:528-534.
9. Branson HE, Katz I, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet. 1983;2:1165-1168.
10. Seligsohn U, Berger A, Abead M, et al. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med. 1984;310:559-562.
11. Leclerc F, Hazelzet J, Jude B, et al. Protein C and S deficiency in severe infectious purpura of children. A collaborative study of 40 cases. Intensive Care Med. 1992;18:202-205.
12. Petäjä J, Peltola K, Sairanen H, et al. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. J Thorac Cardiovasc Surg. 1996;112:665-671.
13. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol. 1990;12:95-104.
14. Fernández JA, Estellés A, Gilabert J, España F, Aznar J. Functional and immunologic protein S in normal pregnant women and in full-term newborns. Thromb Haemost. 1989;61:474-478.
15. Karpatkin M, Mannucci PM, Bhogal M, Vigano S, Nardi M. Low protein C in the neonatal period. Br J Haematol. 1986;62:137-142.
16. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood. 1996;88:900-906.
17. Malm J, Bennhagen R, Holmberg L, Dahlbäck B. Plasma concentrations of C4b-binding protein and vitamin K-dependent protein S in term and preterm infants: low levels of protein S-C4b-binding protein complexes. Br J Haematol. 1988;68:445-449.
18. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998-2005.
19. Melissari E, Nicolaides KH, Scully MF, Kakkar VV. Protein S and C4b-binding protein in fetal and neonatal blood. Br J Haematol. 1988;70:199-203.
20. Suarez CR, Menendez CE, Walenga JM, Farced J. Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic status. Semin Thromb Haemost. 1984;10:280-284.
21. Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost. 1990;63:27-30.
22. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74:415-425.
23. Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood. 1992;79:2340-2348.
24. 506 to glutamine mutation. Stroke. 1996;27:1163-1166.
25. Sun X, Evatt B, Griffin JH. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood. 1994;83:3120-3125.
26. 358. J Biol Chem. 1990;265: 2365-2369.
27. Heeb MJ, Kojima Y, Greengard JS, Griffin JH. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood. 1995;85:3405-3411.
28. Amiral J, Grosley B, Boyer-Neumann C, et al. New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for free form. Blood Coagul Fibrinolysis. 1994;5:179-186.
29. Griffin JH, Gruber A, Fernández JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood. 1992;79:3203-3211.
30. Hackeng TM, van't Veer C, Meijers JCM, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem. 1994;269:21051-21058.
31. Keller FG, Ortel TL, Quinn-Allen MA, Kane WH. Thrombin-catalyzed activation of recombinant human factor V. Biochemistry. 1995;34:4118-4124.
32. Yuen PMP, Yin JA, Lao TTH. Fibrinopeptide A levels in maternal and newborn plasma. Eur J Obstetr Gynecol Reprod Biol. 1989;30:239-244.
33. Boldt J, Knothe C, Schindler E, Welters A, Dapper F, Hempelmann G. Thrombomodulin in pediatric cardiac surgery. Ann Thorac Surg. 1994;57:1584-1589.
34. Aurrousseau MH, Amiral J, Boffa MC. Level of plasma thrombomodulin in neonates and in children. Thromb Haemost. 1991;65 (abstract):1937.
35. Conard J, Bauer KA, Gruber A, et al. Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood. 1993;82:1159-1164.
36. Hanson SR, Griffin JH, Harker La, Kelly A B, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest. 1993;92:2003-2012.
37. Esmon CT. The protein C anticoagulant pathway. Arteriosclr Thromb. 1992;12:135-145.
38. Heeb MJ, España F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood. 1989;73:446-454.
39. 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin. J Biol Chem. 1991;266:17606-17612.
40. Ferńndez JA, España F, Gilabert J, Estellés A, Aznar J. Decreased levels of protein C inhibitor during pregnancy and puerperium. Rev Iberoamer Tromb Hemost. 1991;4:189-192.
41. Fernández JA, Hackeng TM, Kojima K, Griffin JH. The carbohydrate moiety of factor V modulates inactivation by activated protein C. Blood. 1997;89:4348-4354.
42. Griffin JH, Evatt BL, Wideman C, Fernández JA. Anticoagulant protein C pathway is defective in a majority of thrombophilic patients. Blood. 1993;82:1989-1993.
43. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-521.
44. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.
45. Koster T, Rosendaal FR, deRonde H, Briet E, Vandenbroucke JP, Bertina R. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503-1506.
46. Pipe SW, Schmaier AH, Nichols WC, Ginsburg D, Bozynski MEA, Castle VP. Neonatal purpura fulminans in association with factor V R506Q mutation. J Pediatr. 1996; 128:706-709.
47. Kodish E, Potter C, Kirschbaum NE, Foster PA. Activated protein C resistance in a neonate with venous thrombosis. J Pediatr. 1995;127:645-648.
48. Schwarz HP, Muntean W, Wazke H, Richter B, Griffin JH. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood. 1988;71:562-565.
49. Gris J, Biron C, Brun S, et al. Free protein S deficiency in patients with human immunodeficiency virus infection: discrepancies between protein S related assays related to plasma microparticles. Thromb Haemost. 1995;73 (abstract):1426a.